UBS AG Analysts Give Koninklijke Philips NV (AMS:PHIA) a €36.00 Price Target
UBS AG set a €36.00 ($42.35) price objective on Koninklijke Philips NV (AMS:PHIA) in a research note published on Monday, July 24th, www.boersen-zeitung.de reports. The firm currently has a buy rating on the stock.
Other equities analysts have also recently issued reports about the stock. Kepler Capital Markets set a €36.00 ($42.35) price objective on shares of Koninklijke Philips NV and gave the company a buy rating in a research report on Friday, June 2nd. J P Morgan Chase & Co set a €35.00 ($41.18) price objective on shares of Koninklijke Philips NV and gave the company a buy rating in a research report on Monday, May 29th. Citigroup Inc. set a €36.00 ($42.35) target price on shares of Koninklijke Philips NV and gave the company a buy rating in a research note on Thursday, June 22nd. Morgan Stanley set a €27.50 ($32.35) target price on shares of Koninklijke Philips NV and gave the company a neutral rating in a research note on Wednesday, July 5th. Finally, Deutsche Bank AG set a €34.00 ($40.00) target price on shares of Koninklijke Philips NV and gave the company a neutral rating in a research note on Thursday, June 29th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. The stock has an average rating of Buy and an average target price of €33.60 ($39.53).
Shares of Koninklijke Philips NV (AMS PHIA) traded down 1.31% during mid-day trading on Monday, hitting €31.71. The stock had a trading volume of 2,637,529 shares. The stock has a market cap of €29.71 billion and a P/E ratio of 20.17. The company’s 50 day moving average price is €31.82 and its 200 day moving average price is €30.67. Koninklijke Philips NV has a 12-month low of €25.01 and a 12-month high of €34.33.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/19/koninklijke-philips-nv-amsphia-given-a-36-00-price-target-at-ubs-ag-updated-updated-updated.html.
About Koninklijke Philips NV
Koninklijke Philips N.V. is a health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, and Lighting. The Company’s Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Receive News & Stock Ratings for Koninklijke Philips NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips NV and related stocks with our FREE daily email newsletter.